| 000 | 01669 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515175523.0 | ||
| 264 | 0 | _c20110408 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1559-131X | ||
| 024 | 7 |
_a10.1007/s12032-009-9263-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUlusakarya, Ayhan | |
| 245 | 0 | 0 |
_aAcute renal failure related to oxaliplatin-induced intravascular hemolysis. _h[electronic resource] |
| 260 |
_bMedical oncology (Northwood, London, England) _cDec 2010 |
||
| 300 |
_a1425-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 |
_aHemolysis _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aPrognosis |
| 700 | 1 | _aMisra, Srimanta | |
| 700 | 1 | _aHaydar, Mazen | |
| 700 | 1 | _aHabert, Hélène | |
| 700 | 1 | _aCastagne, Vincent | |
| 700 | 1 | _aGumus, Yusuf | |
| 700 | 1 | _aDelmas-Marsalet, Béatrice | |
| 700 | 1 | _aMachover, David | |
| 773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 27 _gno. 4 _gp. 1425-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-009-9263-3 _zAvailable from publisher's website |
| 999 |
_c18982237 _d18982237 |
||